CD4+ Th1 cells amplify cytotoxic T lymphocyte responses by assisting their priming relayed through specific DCs (45), and target tumor cells either directly through cytolytic mechanisms or indirectly by modulating the tumor microenvironment (45). This evidence concerns the gene CD4 and neoplasm.